Nano-oncology: Clinical application for cancer therapy and future perspectives

Journal of Nanomaterials

Volumn 2011, Issue , 2011, Pages

  Riggio, Cristina ^a   Pagni, Eleonora ^a   Raffa, Vittoria ^a   Cuschieri, Alfred ^a  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER THERAPY; CLINICAL APPLICATION; CLINICAL ONCOLOGY; CLINICAL TRIAL; CLINICAL USE; CYTOTOXIC AGENTS; DRUG DELIVERY SYSTEM; FUNCTIONAL MOLECULES; FUTURE PERSPECTIVES; IMAGING PROBE; PHARMACEUTICAL INDUSTRY; PHASE II; POLYMERIC NANOPARTICLES; PRESENT STATUS; RESPONSE RATE; WIDE SPECTRUM;

CHEMOTHERAPY; DISEASES; DRUG DELIVERY; LIPOSOMES; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; PHOSPHOLIPIDS; TUMORS;

ONCOLOGY;

EID: 84855173592     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2011/164506     Document Type: Review

References (40)

1. Ferrari M., Cancer nanotechnology: opportunities and challenges Nature Reviews Cancer 2005 5 3 161 171 (Pubitemid 40314948)
2. Walko C. M., McLeod H., Pharmacogenomic progress in individualized dosing of key drugs for cancer patients Nature Clinical Practice Oncology 2009 6 3 153 162
3. Kwon G. S., Polymeric micelles for delivery of poorly water-soluble compounds Critical Reviews in Therapeutic Drug Carrier Systems 2003 20 5 357 403 (Pubitemid 38129592)
4. Bharali D. J., Mousa S. A., Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise Pharmacology and Therapeutics 2010 128 2 324 335
5. Bangham A.,. The 1st Description of Liposomesa Citation Classic Commentary on Diffusion of Univalent Ions across the Lamellae of Swollen Phospholipids by Bangham,A.D., Standish, M.M., and Watkins, J.C. Current Contents/Life Sciences 1989:14-14
6. Gregoriadis G., The carrier potential of liposomes in biology and medicine. II The New England Journal of Medicine 1976 295 14 765 770
7. Zhang L., Granick S., How to stabilize phospholipid liposomes (using nanoparticles) Nano Letters 2006 6 4 694 698
8. Torchilin V. P., Recent advances with liposomes as pharmaceutical carriers Nature Reviews Drug Discovery 2005 4 2 145 160 (Pubitemid 40282557)
9. Qiu L., Jing N., Jin Y., Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method International Journal of Pharmaceutics 2008 361 1-2 56 63
10. Hoffman A. S., The origins and evolution of controlled drug delivery systems Journal of Controlled Release 2008 132 3 153 163
11. Oerlemans C., Bult W., Bos M., Storm G., Nijsen J. F. W., Hennink W. E., Polymeric micelles in anticancer therapy: targeting, imaging and triggered release Pharmaceutical Research 2010 27 2569 2589
12. Hu K., Li J., Shen Y., Lu W., Gao X., Zhang Q., Jiang X., Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations Journal of Controlled Release 2009 134 1 55 61
13. Cheng J., Teply B. A., Sherifi I., Sung J., Luther G., Gu F. X., Levy-Nissenbaum E., Radovic-Moreno A. F., Langer R., Farokhzad O. C., Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery Biomaterials 2007 28 5 869 876 (Pubitemid 44667020)
14. Chan J. M., Zhang L., Yuet K. P., Liao G., Rhee J. W., Langer R., Farokhzad O. C., PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery Biomaterials 2009 30 8 1627 1634
15. Liu Z., Jiao Y., Wang Y., Zhou C., Zhang Z., Polysaccharides-based nanoparticles as drug delivery systems Advanced Drug Delivery Reviews 2008 60 15 1650 1662
16. Bajpai A. K., Shukla S. K., Bhanu S., Kankane S., Responsive polymers in controlled drug delivery Progress in Polymer Science 2008 33 11 1088 1118
17. Peer D., Karp J. M., Hong S., Farokhzad O. C., Margalit R., Langer R., Nanocarriers as an emerging platform for cancer therapy Nature Nanotechnology 2007 2 12 751 760 (Pubitemid 350223348)
18. Kukowska-Latallo J. F., Candido K. A., Cao Z., Nigavekar S. S., Majoros I. J., Thomas T. P., Balogh L. P., Khan M. K., Baker J. R., Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer Cancer Research 2005 65 12 5317 5324 (Pubitemid 40827344)
19. Mody V. V., Siwale R., Singh A., Mody H. R., Introduction to metallic nanoparticles Journal of Pharmacy and Bioallied Science 2010 2 282 289
20. Cherukuri P., Glazer E. S., Curley S. A., Targeted hyperthermia using metal nanoparticles Advanced Drug Delivery Reviews 2010 62 3 339 345
21. Loo C., Lin A., Hirsch L., Lee M. H., Barton J., Halas N., West J., Drezek R., Nanoshell-enabled photonics-based imaging and therapy of cancer Technology in Cancer Research and Treatment 2004 3 1 33 40 (Pubitemid 38250466)
22. Gobin A. M., Lee M. H., Halas N. J., James W. D., Drezek R. A., West J. L., Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy Nano Letters 2007 7 7 1929 1934 (Pubitemid 47197569)
23. Hirsch L. R., Stafford R. J., Bankson J. A., Sershen S. R., Rivera B., Price R. E., Hazle J. D., Halas N. J., West J. L., Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance Proceedings of the National Academy of Sciences of the United States of America 2003 100 23 13549 13554 (Pubitemid 37444779)
24. Fu K., Sun J., Lin A. W. H., Wang H., Halas N. J., Drezek R. A., Polarized angular dependent light scattering properties of bare and PEGylated gold nanoshells Current Nanoscience 2007 3 2 167 170 (Pubitemid 46845722)
25. Loo C., Hirsch L., Lee M. H., Chang E., West J., Halas N., Drezek R., Gold nanoshell bioconjugates for molecular imaging in living cells Optics Letters 2005 30 9 1012 1014 (Pubitemid 40749266)
26. Hirsch L. R., Gobin A. M., Lowery A. R., Tam F., Drezek R. A., Halas N. J., West J. L., Metal nanoshells Annals of Biomedical Engineering 2006 34 1 15 22
27. Davis M. E., Chen Z., Shin D. M., Nanoparticle therapeutics: an emerging treatment modality for cancer Nature Reviews Drug Discovery 2008 7 9 771 782
28. Hofheinz R. D., Gnad-Vogt S. U., Beyer U., Hochhaus A., Liposomal encapsulated anti-cancer drugs Anti-Cancer Drugs 2005 16 7 691 707 (Pubitemid 41104918)
29. Harris L., Batist G., Belt R., Rovira D., Navari R., Azarnia N., Welles L., Winer E., Garrett T., Blayney D., Elias L., Mortimer J., Needles B., Webb T., Atiba J., Bickers J., Godfrey T., Love R., Osborn D., Aisner J., Anderson T., Butler D., Calabresi P., Feldman L., Kerr R., Nevinny H., Reynolds C., Schneider A., Tweedy C., Whaley W., Demattia M., Harper G., Moroose R., Staszewski H., Begas A., Dutcher J., Ellis R., Fleming G., Garcia M., Granick J., Kloss J., Roberts M., Sanchez F., Silver R., Taylor H., Liposome- encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma Cancer 2002 94 1 25 36 (Pubitemid 34049039)
30. Seetharamu N., Kim E., Hochster H., Martin F., Muggia F., Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer Anticancer Research 2010 30 2 541 545
31. Gradishar W. J., Tjulandin S., Davidson N., Shaw H., Desai N., Bhar P., Hawkins M., O'Shaughnessy J., Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer Journal of Clinical Oncology 2005 23 31 7794 7803 (Pubitemid 46657376)
32. Gradishar W., Vishalpura T., Franklin M., Bramley T., Cost-effectiveness of nanoparticle albumin-bound paclitaxel versus docetaxel in the treatment of metastatic breast cancer Breast Cancer Research and Treatment 2005 94 S220 S221
33. Kim S. C., Kim D. W., Shim Y. H., Bang J. S., Oh H. S., Kim S. W., Seo M. H., In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy Journal of Controlled Release 2001 72 13 191 202 (Pubitemid 32522357)
34. Kim T. Y., Kim D. W., Chung J. Y., Shin S. G., Kim S. C., Heo D. S., Kim N. K., Bang Y. J., Phase I and pharmacokinetic study of Genexol-PM, a Cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies Clinical Cancer Research 2004 10 11 3708 3716 (Pubitemid 38697604)
35. Tan E., Leong S. S., Lim W. T., Toh C. K., Chowbay B., Weekly administration of a Cremophor-free, polymeric micelle formulation of paclitaxel to Asian patients with advanced solid tumor: phase I study results Proceedings of the Gastrointestinal Cancers Symposium 2007
36. Lee K. S., Chung H. C., Im S. A., Park Y. H., Kim C. S., Kim S. B., Rha S. Y., Lee M. Y., Ro J., Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Breast Cancer Research and Treatment 2008 108 2 241 250 (Pubitemid 351311357)
37. Saif M. W., Rubin M., Figueroa J., Kerr R. O., Multicenter phase II trial of Genexol-PM (GPM), a novel Cremophor-free, polymeric micelle formulation of paclitaxel in patients with advanced pancreatic cancer (APC): final results Proceedings of the Gastrointestinal Cancers Symposium 2008
38. Kim D. W., Kim S. Y., Kim H. K., Kim S. W., Shin S. W., Kim J. S., Park K., Lee M. Y., Heo D. S., Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer Annals of Oncology 2007 18 12 2009 2014 (Pubitemid 350286241)
39. Sanvicens N., Marco M. P., Multifunctional nanoparticlesproperties and prospects for their use in human medicine Trends in Biotechnology 2008 26 8 425 433
40. Murday J. S., Siegel R. W., Stein J., Wright J. F., Translational nanomedicine: status assessment and opportunities Nanomedicine: Nanotechnology, Biology, and Medicine 2009 5 3 251 273